"V体育官网" PharmGKB summary: methotrexate pathway
- PMID: 21317831
- PMCID: PMC3139712
- DOI: 10.1097/FPC.0b013e328343dd93
"V体育2025版" PharmGKB summary: methotrexate pathway
Figures

References
-
- Dervieux T, Wessels JA, Van der ST, Penrod N, Moore JH, Guchelaar HJ, et al. Gene–gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis. Pharmacogenet Genomics. 2009;19:935–944. - PubMed
-
- Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741. - V体育官网 - PMC - PubMed
-
- Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, et al. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer. 2004;100:2222–2232. - PubMed
-
- Trevino LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, et al. Germ line genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol. 2009;27:5972–5978. - PMC (VSports最新版本) - PubMed
-
- Buitenkamp TD, Mathot RAA, de Haas V, Pieters R, Zwaan CM. Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia. Haematologica. 2010;95:1106–1113. - PMC (VSports) - PubMed
Publication types
MeSH terms (V体育平台登录)
- "V体育平台登录" Actions
- Actions (VSports手机版)
- "VSports app下载" Actions
- "V体育2025版" Actions
- V体育安卓版 - Actions
Substances
- Actions (VSports最新版本)
Grants and funding
LinkOut - more resources
"V体育官网" Full Text Sources
"VSports注册入口" Medical